Webinar | Small Portions, Big Satiety: The Rise of GLP-1 Inspired Foods Register Now

Acornmed

Acornmed provides clinical oncology solutions.
2019
11-50
Haidian, Beijing, China
  • Oncology (Cancer)
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Investment Funding

Last Funding Stage

Series B

Total Funding Amount

28.74M

Last Funding Amount

28.74M

Last Funding Date

27-12-2022

Startup Stage

Early Stage

Lead Investors

Sino-Ocean Group, Pickup Capital, Indaco Capital, Lingxian Ziben

Something missing or incorrect on this page? Help us enrich this information